HCA Healthcare, Inc. Logo

HCA Healthcare, Inc.

HCA

(3.5)
Stock Price

303,62 USD

12.1% ROA

-330.72% ROE

17.37x PER

Market Cap.

97.701.654.920,00 USD

-2555% DER

0.68% Yield

8.52% NPM

HCA Healthcare, Inc. Stock Analysis

HCA Healthcare, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

HCA Healthcare, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

2 PBV

The stock's low PBV ratio (-27.05x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-1660%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

5 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

6 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

7 Dividend Growth

With a history of consistent dividend increases over the last three years, the company has proven to be a reliable choice for investors seeking reliable income.

8 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (3.226), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

9 ROE

Negative ROE (-227.68%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

10 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

11 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

HCA Healthcare, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

HCA Healthcare, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

HCA Healthcare, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

HCA Healthcare, Inc. Revenue
Year Revenue Growth
1990 272.600.000
1991 461.000.000 40.87%
1992 761.600.000 39.47%
1993 10.252.000.000 92.57%
1994 11.132.000.000 7.91%
1995 17.695.000.000 37.09%
1996 19.909.000.000 11.12%
1997 18.819.000.000 -5.79%
1998 18.681.000.000 -0.74%
1999 16.657.000.000 -12.15%
2000 16.670.000.000 0.08%
2001 17.953.000.000 7.15%
2002 19.729.000.000 9%
2003 21.808.000.000 9.53%
2004 23.502.000.000 7.21%
2005 24.455.000.000 3.9%
2006 25.477.000.000 4.01%
2007 26.858.000.000 5.14%
2008 28.374.000.000 5.34%
2009 30.052.000.000 5.58%
2010 30.683.000.000 2.06%
2011 32.506.000.000 5.61%
2012 33.013.000.000 1.54%
2013 34.182.000.000 3.42%
2014 36.918.000.000 7.41%
2015 39.678.000.000 6.96%
2016 41.490.000.000 4.37%
2017 43.614.000.000 4.87%
2018 46.677.000.000 6.56%
2019 51.336.000.000 9.08%
2020 51.533.000.000 0.38%
2021 58.752.000.000 12.29%
2022 60.233.000.000 2.46%
2023 64.852.000.000 7.12%
2023 64.968.000.000 0.18%
2024 69.968.000.000 7.15%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

HCA Healthcare, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

HCA Healthcare, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 9.928.000.000 100%
2006 10.409.000.000 4.62%
2007 10.714.000.000 2.85%
2008 11.440.000.000 6.35%
2009 11.958.000.000 4.33%
2010 12.484.000.000 4.21%
2011 13.440.000.000 7.11%
2012 15.089.000.000 10.93%
2013 15.646.000.000 3.56%
2014 16.641.000.000 5.98%
2015 18.115.000.000 8.14%
2016 18.897.000.000 4.14%
2017 20.059.000.000 5.79%
2018 21.425.000.000 6.38%
2019 23.560.000.000 9.06%
2020 23.874.000.000 1.32%
2021 26.779.000.000 10.85%
2022 27.685.000.000 3.27%
2023 30.224.000.000 8.4%
2023 29.487.000.000 -2.5%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

HCA Healthcare, Inc. EBITDA
Year EBITDA Growth
1990 11.400.000
1991 3.900.000 -192.31%
1992 21.400.000 81.78%
1993 2.068.000.000 98.97%
1994 2.117.000.000 2.31%
1995 3.333.000.000 36.48%
1996 4.309.000.000 22.65%
1997 2.991.000.000 -44.07%
1998 3.723.000.000 19.66%
1999 3.301.000.000 -12.78%
2000 2.433.000.000 -35.68%
2001 3.355.000.000 27.48%
2002 3.078.000.000 -9%
2003 4.039.000.000 23.79%
2004 3.966.000.000 -1.84%
2005 3.922.000.000 -1.12%
2006 4.469.000.000 12.24%
2007 4.584.000.000 2.51%
2008 4.116.000.000 -11.37%
2009 5.457.000.000 24.57%
2010 5.868.000.000 7%
2011 6.061.000.000 3.18%
2012 6.531.000.000 7.2%
2013 6.574.000.000 0.65%
2014 7.428.000.000 11.5%
2015 7.915.000.000 6.15%
2016 8.218.000.000 3.69%
2017 8.233.000.000 0.18%
2018 8.949.000.000 8%
2019 9.857.000.000 9.21%
2020 10.037.000.000 1.79%
2021 12.644.000.000 20.62%
2022 12.067.000.000 -4.78%
2023 11.520.000.000 -4.75%
2023 12.726.000.000 9.48%
2024 14.200.000.000 10.38%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

HCA Healthcare, Inc. Gross Profit
Year Gross Profit Growth
1990 191.300.000
1991 325.700.000 41.26%
1992 531.100.000 38.67%
1993 6.740.000.000 92.12%
1994 11.132.000.000 39.45%
1995 17.695.000.000 37.09%
1996 19.909.000.000 11.12%
1997 18.819.000.000 -5.79%
1998 18.681.000.000 -0.74%
1999 16.657.000.000 -12.15%
2000 16.670.000.000 0.08%
2001 17.953.000.000 7.15%
2002 19.729.000.000 9%
2003 21.808.000.000 9.53%
2004 23.502.000.000 7.21%
2005 20.329.000.000 -15.61%
2006 21.155.000.000 3.9%
2007 22.463.000.000 5.82%
2008 23.754.000.000 5.43%
2009 13.226.000.000 -79.6%
2010 25.722.000.000 48.58%
2011 27.327.000.000 5.87%
2012 27.296.000.000 -0.11%
2013 28.212.000.000 3.25%
2014 30.656.000.000 7.97%
2015 33.040.000.000 7.22%
2016 34.557.000.000 4.39%
2017 36.298.000.000 4.8%
2018 38.953.000.000 6.82%
2019 42.855.000.000 9.11%
2020 43.164.000.000 0.72%
2021 49.271.000.000 12.39%
2022 50.862.000.000 3.13%
2023 55.184.000.000 7.83%
2023 55.066.000.000 -0.21%
2024 10.924.000.000 -404.08%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

HCA Healthcare, Inc. Net Profit
Year Net Profit Growth
1990 9.800.000
1991 15.200.000 35.53%
1992 25.500.000 40.39%
1993 507.000.000 94.97%
1994 630.000.000 19.52%
1995 961.000.000 34.44%
1996 1.505.000.000 36.15%
1997 -305.000.000 593.44%
1998 379.000.000 180.47%
1999 657.000.000 42.31%
2000 219.000.000 -200%
2001 886.000.000 75.28%
2002 833.000.000 -6.36%
2003 1.332.000.000 37.46%
2004 1.246.000.000 -6.9%
2005 1.424.000.000 12.5%
2006 1.036.000.000 -37.45%
2007 874.000.000 -18.54%
2008 673.000.000 -29.87%
2009 1.054.000.000 36.15%
2010 1.207.000.000 12.68%
2011 2.465.000.000 51.03%
2012 1.605.000.000 -53.58%
2013 1.556.000.000 -3.15%
2014 1.875.000.000 17.01%
2015 2.129.000.000 11.93%
2016 2.890.000.000 26.33%
2017 2.216.000.000 -30.42%
2018 3.787.000.000 41.48%
2019 3.505.000.000 -8.05%
2020 3.754.000.000 6.63%
2021 6.956.000.000 46.03%
2022 5.643.000.000 -23.27%
2023 4.316.000.000 -30.75%
2023 5.242.000.000 17.67%
2024 5.844.000.000 10.3%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

HCA Healthcare, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1990 1
1991 1 0%
1992 1 0%
1993 1 100%
1994 2 0%
1995 1 0%
1996 2 50%
1997 0 0%
1998 1 0%
1999 1 100%
2000 0 0%
2001 2 100%
2002 2 0%
2003 3 50%
2004 3 0%
2005 3 33.33%
2006 3 -50%
2007 3 0%
2008 2 -100%
2009 3 66.67%
2010 3 -50%
2011 5 60%
2012 4 -66.67%
2013 4 0%
2014 4 25%
2015 5 20%
2016 8 28.57%
2017 6 -16.67%
2018 11 45.45%
2019 10 -10%
2020 11 9.09%
2021 22 47.62%
2022 19 -10.53%
2023 16 -26.67%
2023 19 21.05%
2024 22 13.64%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

HCA Healthcare, Inc. Free Cashflow
Year Free Cashflow Growth
1990 -4.100.000
1991 -20.000.000 79.5%
1992 -36.600.000 45.36%
1993 462.000.000 107.92%
1994 326.000.000 -41.72%
1995 727.000.000 55.16%
1996 1.221.000.000 40.46%
1997 61.000.000 -1901.64%
1998 661.000.000 90.77%
1999 -64.000.000 1132.81%
2000 392.000.000 116.33%
2001 43.000.000 -811.63%
2002 1.032.000.000 95.83%
2003 328.000.000 -214.63%
2004 1.536.000.000 78.65%
2005 1.567.000.000 1.98%
2006 -20.000.000 7935%
2007 -48.000.000 58.33%
2008 197.000.000 124.37%
2009 1.430.000.000 86.22%
2010 1.760.000.000 18.75%
2011 2.254.000.000 21.92%
2012 2.313.000.000 2.55%
2013 1.737.000.000 -33.16%
2014 2.272.000.000 23.55%
2015 2.359.000.000 3.69%
2016 2.893.000.000 18.46%
2017 2.411.000.000 -19.99%
2018 3.188.000.000 24.37%
2019 3.444.000.000 7.43%
2020 6.397.000.000 46.16%
2021 5.382.000.000 -18.86%
2022 4.127.000.000 -30.41%
2023 4.687.000.000 11.95%
2023 1.332.000.000 -251.88%
2024 690.000.000 -93.04%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

HCA Healthcare, Inc. Operating Cashflow
Year Operating Cashflow Growth
1990 14.000.000
1991 25.800.000 45.74%
1992 66.800.000 61.38%
1993 1.298.000.000 94.85%
1994 1.301.000.000 0.23%
1995 2.254.000.000 42.28%
1996 2.621.000.000 14%
1997 1.483.000.000 -76.74%
1998 1.916.000.000 22.6%
1999 1.223.000.000 -56.66%
2000 1.547.000.000 20.94%
2001 1.413.000.000 -9.48%
2002 2.750.000.000 48.62%
2003 2.166.000.000 -26.96%
2004 3.049.000.000 28.96%
2005 3.159.000.000 3.48%
2006 1.845.000.000 -71.22%
2007 1.396.000.000 -32.16%
2008 1.797.000.000 22.31%
2009 2.747.000.000 34.58%
2010 3.085.000.000 10.96%
2011 3.933.000.000 21.56%
2012 4.175.000.000 5.8%
2013 3.680.000.000 -13.45%
2014 4.448.000.000 17.27%
2015 4.734.000.000 6.04%
2016 5.653.000.000 16.26%
2017 5.426.000.000 -4.18%
2018 6.761.000.000 19.75%
2019 7.602.000.000 11.06%
2020 9.232.000.000 17.66%
2021 8.959.000.000 -3.05%
2022 8.522.000.000 -5.13%
2023 9.431.000.000 9.64%
2023 2.479.000.000 -280.44%
2024 1.971.000.000 -25.77%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

HCA Healthcare, Inc. Capital Expenditure
Year Capital Expenditure Growth
1990 18.100.000
1991 45.800.000 60.48%
1992 103.400.000 55.71%
1993 836.000.000 87.63%
1994 975.000.000 14.26%
1995 1.527.000.000 36.15%
1996 1.400.000.000 -9.07%
1997 1.422.000.000 1.55%
1998 1.255.000.000 -13.31%
1999 1.287.000.000 2.49%
2000 1.155.000.000 -11.43%
2001 1.370.000.000 15.69%
2002 1.718.000.000 20.26%
2003 1.838.000.000 6.53%
2004 1.513.000.000 -21.48%
2005 1.592.000.000 4.96%
2006 1.865.000.000 14.64%
2007 1.444.000.000 -29.16%
2008 1.600.000.000 9.75%
2009 1.317.000.000 -21.49%
2010 1.325.000.000 0.6%
2011 1.679.000.000 21.08%
2012 1.862.000.000 9.83%
2013 1.943.000.000 4.17%
2014 2.176.000.000 10.71%
2015 2.375.000.000 8.38%
2016 2.760.000.000 13.95%
2017 3.015.000.000 8.46%
2018 3.573.000.000 15.62%
2019 4.158.000.000 14.07%
2020 2.835.000.000 -46.67%
2021 3.577.000.000 20.74%
2022 4.395.000.000 18.61%
2023 4.744.000.000 7.36%
2023 1.147.000.000 -313.6%
2024 1.281.000.000 10.46%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

HCA Healthcare, Inc. Equity
Year Equity Growth
1990 57.100.000
1991 141.300.000 59.59%
1992 296.100.000 52.28%
1993 3.528.000.000 91.61%
1994 5.280.000.000 33.18%
1995 7.851.000.000 32.75%
1996 9.445.000.000 16.88%
1997 8.086.000.000 -16.81%
1998 8.346.000.000 3.12%
1999 6.380.000.000 -30.82%
2000 4.977.000.000 -28.19%
2001 5.325.000.000 6.54%
2002 6.313.000.000 15.65%
2003 6.889.000.000 8.36%
2004 5.216.000.000 -32.07%
2005 5.691.000.000 8.35%
2006 -10.467.000.000 154.37%
2007 -9.600.000.000 -9.03%
2008 -9.260.000.000 -3.67%
2009 -7.978.000.000 -16.07%
2010 -10.794.000.000 26.09%
2011 -7.014.000.000 -53.89%
2012 -8.341.000.000 15.91%
2013 -6.928.000.000 -20.4%
2014 -6.498.000.000 -6.62%
2015 -6.046.000.000 -7.48%
2016 -5.633.000.000 -7.33%
2017 -4.995.000.000 -12.77%
2018 -2.918.000.000 -71.18%
2019 -565.000.000 -416.46%
2020 2.892.000.000 119.54%
2021 1.489.000.000 -94.22%
2022 -73.000.000 2139.73%
2023 357.000.000 120.45%
2023 1.060.000.000 66.32%
2024 1.339.000.000 20.84%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

HCA Healthcare, Inc. Assets
Year Assets Growth
1990 321.600.000
1991 485.300.000 33.73%
1992 1.072.000.000 54.73%
1993 10.216.000.000 89.51%
1994 12.339.000.000 17.21%
1995 19.892.000.000 37.97%
1996 21.272.000.000 6.49%
1997 22.002.000.000 3.32%
1998 19.429.000.000 -13.24%
1999 16.885.000.000 -15.07%
2000 17.568.000.000 3.89%
2001 17.730.000.000 0.91%
2002 18.741.000.000 5.39%
2003 21.063.000.000 11.02%
2004 21.465.000.000 1.87%
2005 22.225.000.000 3.42%
2006 23.675.000.000 6.12%
2007 24.025.000.000 1.46%
2008 24.280.000.000 1.05%
2009 24.131.000.000 -0.62%
2010 23.852.000.000 -1.17%
2011 26.898.000.000 11.32%
2012 28.075.000.000 4.19%
2013 28.831.000.000 2.62%
2014 31.199.000.000 7.59%
2015 32.744.000.000 4.72%
2016 33.758.000.000 3%
2017 36.593.000.000 7.75%
2018 39.207.000.000 6.67%
2019 45.058.000.000 12.99%
2020 47.490.000.000 5.12%
2021 50.742.000.000 6.41%
2022 52.438.000.000 3.23%
2023 54.589.000.000 3.94%
2023 56.211.000.000 2.89%
2024 57.379.000.000 2.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

HCA Healthcare, Inc. Liabilities
Year Liabilities Growth
1990 264.500.000
1991 344.000.000 23.11%
1992 775.900.000 55.66%
1993 6.688.000.000 88.4%
1994 7.059.000.000 5.26%
1995 12.041.000.000 41.38%
1996 11.827.000.000 -1.81%
1997 13.916.000.000 15.01%
1998 11.083.000.000 -25.56%
1999 10.505.000.000 -5.5%
2000 12.591.000.000 16.57%
2001 12.405.000.000 -1.5%
2002 12.428.000.000 0.19%
2003 14.174.000.000 12.32%
2004 16.249.000.000 12.77%
2005 16.534.000.000 1.72%
2006 34.142.000.000 51.57%
2007 33.625.000.000 -1.54%
2008 33.540.000.000 -0.25%
2009 32.109.000.000 -4.46%
2010 34.646.000.000 7.32%
2011 33.912.000.000 -2.16%
2012 36.416.000.000 6.88%
2013 35.759.000.000 -1.84%
2014 37.697.000.000 5.14%
2015 38.790.000.000 2.82%
2016 39.391.000.000 1.53%
2017 41.588.000.000 5.28%
2018 42.125.000.000 1.27%
2019 45.623.000.000 7.67%
2020 44.598.000.000 -2.3%
2021 49.253.000.000 9.45%
2022 52.511.000.000 6.2%
2023 54.232.000.000 3.17%
2023 55.151.000.000 1.67%
2024 56.040.000.000 1.59%

HCA Healthcare, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
259.66
Net Income per Share
21.8
Price to Earning Ratio
17.37x
Price To Sales Ratio
1.43x
POCF Ratio
10.39
PFCF Ratio
19.99
Price to Book Ratio
-62.28
EV to Sales
2.04
EV Over EBITDA
10.42
EV to Operating CashFlow
14.56
EV to FreeCashFlow
28.57
Earnings Yield
0.06
FreeCashFlow Yield
0.05
Market Cap
97,70 Bil.
Enterprise Value
139,64 Bil.
Graham Number
54.6
Graham NetNet
-176.76

Income Statement Metrics

Net Income per Share
21.8
Income Quality
1.62
ROE
-3.07
Return On Assets
0.1
Return On Capital Employed
0.24
Net Income per EBT
0.68
EBT Per Ebit
0.83
Ebit per Revenue
0.15
Effective Tax Rate
0.22

Margins

Sales, General, & Administrative to Revenue
0.33
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.5
Operating Profit Margin
0.15
Pretax Profit Margin
0.13
Net Profit Margin
0.09

Dividends

Dividend Yield
0.01
Dividend Yield %
0.68
Payout Ratio
0.12
Dividend Per Share
2.58

Operating Metrics

Operating Cashflow per Share
36.45
Free CashFlow per Share
18.57
Capex to Operating CashFlow
0.49
Capex to Revenue
0.07
Capex to Depreciation
1.48
Return on Invested Capital
0.2
Return on Tangible Assets
0.12
Days Sales Outstanding
54.68
Days Payables Outstanding
42.58
Days of Inventory on Hand
19.02
Receivables Turnover
6.68
Payables Turnover
8.57
Inventory Turnover
19.19
Capex per Share
17.88

Balance Sheet

Cash per Share
3,55
Book Value per Share
5,09
Tangible Book Value per Share
-32.76
Shareholders Equity per Share
-6.08
Interest Debt per Share
162.88
Debt to Equity
-25.55
Debt to Assets
0.71
Net Debt to EBITDA
3.13
Current Ratio
1.06
Tangible Asset Value
-8,62 Bil.
Net Current Asset Value
-40,87 Bil.
Invested Capital
41653000000
Working Capital
0,87 Bil.
Intangibles to Total Assets
0.17
Average Receivables
10,14 Bil.
Average Payables
4,38 Bil.
Average Inventory
1851500000
Debt to Market Cap
0.42

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

HCA Healthcare, Inc. Dividends
Year Dividends Growth
2012 7
2018 1 -500%
2019 2 0%
2020 1 0%
2021 2 100%
2022 2 50%
2023 2 0%
2024 2 -100%

HCA Healthcare, Inc. Profile

About HCA Healthcare, Inc.

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

CEO
Mr. Samuel N. Hazen
Employee
220.000
Address
One Park Plaza
Nashville, 37203

HCA Healthcare, Inc. Executives & BODs

HCA Healthcare, Inc. Executives & BODs
# Name Age
1 Mr. Christopher F. Wyatt
Senior Vice President, Principal Accounting Officer & Controller
70
2 Mr. Jon Mack Foster
Executive Vice President & Chief Operating Officer
70
3 Mr. Timothy M. McManus
President of National Group
70
4 Mr. Michael R. McAlevey
Executive Vice President and Chief Legal & Administrative Officer
70
5 Dr. Thomas F. Frist Jr., M.D.
Founder & Chairman Emeritus
70
6 Mr. Frank George Morgan C.F.A.
Vice President of Investor Relations
70
7 Mr. Chad J. Wasserman
Senior Vice President & Chief Information Officer
70
8 Mr. Michael A. Marks
Chief Financial Officer & Executive Vice President
70
9 Mr. Samuel N. Hazen
Chief Executive Officer & Director
70
10 Mr. Erol R. Akdamar FACHE
President of American Group
70

HCA Healthcare, Inc. Competitors